Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Correspondence:
View responses
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kaufmann, P.
Right arrow Articles by De Vivo, D. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kaufmann, P.
Right arrow Articles by De Vivo, D. C.
Related Collections
Right arrow MRS
Right arrow Electrolyte
Right arrow Muscle disease
Right arrow Mitochondrial disorders
NEUROLOGY 2004;62:1297-1302
© 2004 American Academy of Neurology

Cerebral lactic acidosis correlates with neurological impairment in MELAS

P. Kaufmann, MD MSc, D. C. Shungu, PhD, M. C. Sano, PhD, S. Jhung, BS, K. Engelstad, BS, E. Mitsis, PhD, X. Mao, MS, S. Shanske, PhD, M. Hirano, MD, S. DiMauro, MD and D. C. De Vivo, MD

From the Departments of Neurology (Drs. Kaufmann, Sano, Mitsis, Shanske, Hirano, DiMauro, and De Vivo, and S. Jhung and K. Engelstad), Pediatrics (S. Jhung and K. Engelstad, and Dr. De Vivo), and Radiology (Dr. Shungu and X. Mao), The Gertrude H. Sergievsky Center (Dr. Sano), Columbia University, New York, NY.

Address correspondence and reprint requests to Dr. Darryl C. De Vivo, The Neurological Institute, Columbia University, 710 W 168th Street, New York, NY 10032; e-mail: dcd1{at}columbia.edu

Objective: To evaluate the role of chronic cerebral lactic acidosis in mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS).

Methods: The authors studied 91 individuals from 34 families with MELAS and the A3243G point mutation and 15 individuals from two families with myoclonus epilepsy and ragged red fibers (MERRF) and the A8344G mutation. Subjects were divided into four groups. Paternal relatives were studied as controls (Group 1). The maternally related subjects were divided clinically into three groups: asymptomatic (no clinical evidence of neurologic disease) (Group 2), oligosymptomatic (neurologic symptoms but without the full clinical picture of MELAS or MERRF) (Group 3), and symptomatic (fulfilling MELAS or MERRF criteria) (Group 4). The authors performed a standardized neurologic examination, neuropsychological testing, MRS, and leukocyte DNA analysis in all subjects.

Results: The symptomatic and oligosymptomatic MELAS subjects had significantly higher ventricular lactate than the other groups. There was a significant correlation between degree of neuropsychological and neurologic impairment and cerebral lactic acidosis as estimated by ventricular MRS lactate levels.

Conclusions: High levels of ventricular lactate, the brain spectroscopic signature of MELAS, are associated with more severe neurologic impairment.

Received May 6, 2003. Accepted in final form December 15, 2003.




This article has been cited by other articles:


Home page
 NeurologyHome page
C. L. Morgia, A. Achilli, L. Iommarini, P. Barboni, M. Pala, A. Olivieri, C. Zanna, S. Vidoni, C. Tonon, R. Lodi, et al.
Rare mtDNA variants in Leber hereditary optic neuropathy families with recurrence of myoclonus
Neurology, March 4, 2008; 70(10): 762 - 770.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
J. Finsterer
A 3-year clinical follow-up of adult patients with 3243A>G in mitochondrial DNA
Neurology, January 9, 2007; 68(2): 163 - 164.
[Full Text] [PDF]

Home page
 Arch NeurolHome page
S. DiMauro and M. Hirano
Pedaling From Genotype to Phenotype
Arch Neurol, December 1, 2006; 63(12): 1679 - 1680.
[Full Text] [PDF]

Home page
 NeurologyHome page
I. A. Anselm, B. T. Darras, P. Kaufmann, and D. De Vivo
Dichloroacetate causes toxic neuropathy in MELAS: A randomized, controlled clinical trial.
Neurology, October 10, 2006; 67(7): 1313 - 1313.
[Full Text] [PDF]

Home page
 NeurologyHome page
H. Savolainen, P. Kaufmann, and D. C. D. Vivo
Dichloroacetate causes toxic neuropathy in MELAS: A randomized, controlled clinical trial.
Neurology, July 11, 2006; 67(1): 184 - 184.
[Full Text] [PDF]

Home page
 Arch NeurolHome page
P. Kaufmann, J. M. Pascual, Y. Anziska, C. L. Gooch, K. Engelstad, S. Jhung, S. DiMauro, and D. C. De Vivo
Nerve Conduction Abnormalities in Patients With MELAS and the A3243G Mutation.
Arch Neurol, May 1, 2006; 63(5): 746 - 748.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
A. M. Schaefer
Trial of dichloroacetate in MELAS: Toxicity overshadows the assessment of potential benefit
Neurology, February 14, 2006; 66(3): 302 - 303.
[Full Text] [PDF]

Home page
 NeurologyHome page
P. Kaufmann, K. Engelstad, Y. Wei, S. Jhung, M. C. Sano, D. C. Shungu, W. S. Millar, X. Hong, C. L. Gooch, X. Mao, et al.
Dichloroacetate causes toxic neuropathy in MELAS: A randomized, controlled clinical trial
Neurology, February 14, 2006; 66(3): 324 - 330.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
K. Abe, P. Kaufmann, D. C. Shungu, and D. C. De Vivo
Cerebral lactic acidosis correlates with neurological impairment in MELAS
Neurology, December 28, 2004; 63(12): 2458 - 2458.
[Full Text] [PDF]

Correspondence:

Read all Correspondence

Cerebral lactic acidosis correlates with neurological impairment in MELAS
Kazuo Abe, et al.
Neurology Online, 6 Jul 2004 [Full text]
Reply to Abe
Petra Kaufmann, MD, et al.
Neurology Online, 6 Jul 2004 [Full text]

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by AAN Enterprises, Inc.